NM_000256.3:c.1789C>T
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM5PP3_Strong
The NM_000256.3(MYBPC3):c.1789C>T(p.Arg597Trp) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000034 in 1,558,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R597Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000256.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 4Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- left ventricular noncompaction 10Inheritance: AR, AD Classification: DEFINITIVE, MODERATE, LIMITED Submitted by: Ambry Genetics
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- atrial fibrillationInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.1789C>T | p.Arg597Trp | missense_variant, splice_region_variant | Exon 18 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.1789C>T | p.Arg597Trp | missense_variant, splice_region_variant | Exon 17 of 34 | 5 | ENSP00000382193.2 | |||
MYBPC3 | ENST00000544791.1 | n.1789C>T | splice_region_variant, non_coding_transcript_exon_variant | Exon 18 of 27 | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152018Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000297 AC: 5AN: 168412 AF XY: 0.0000562 show subpopulations
GnomAD4 exome AF: 0.0000320 AC: 45AN: 1406648Hom.: 0 Cov.: 32 AF XY: 0.0000317 AC XY: 22AN XY: 694438 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152018Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74234 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:6
- -
- -
proposed classification - variant undergoing re-assessment, contact laboratory -
- -
Identified in unrelated patients with HCM and ARVC in published literature as well as in patients with HCM, LVNC, or DCM referred for genetic testing at GeneDx, although at least one individual harbored an additional variant that likely contributed to disease (PMID: 35208637, 36788754, 37652022, 25524337, 27532257, 33782553, Serio A et al., European Society of Cardiology Working Group. Myocardial and Pericardial diseases Newsletter; March, 2009); Identified in a pediatric patient with HCM who also harbored a pathogenic variant in the MYBPC3 gene in trans (PMID: 30896616); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25524337, 28679633, 33258288, 33782553, 35208637, 36788754, 37652022, 27532257, 30896616) -
- -
Hypertrophic cardiomyopathy Pathogenic:1Uncertain:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 597 of the MYBPC3 protein (p.Arg597Trp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with hypertrophic cardiomyopathy (PMID: 25524337, 27532257, 30896616, 33782553, 36788754, 37652022). ClinVar contains an entry for this variant (Variation ID: 179549). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
This missense variant replaces arginine with tryptophan at codon 597 of the MYBPC3 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant.This variant has been reported in two unrelated individuals affected with hypertrophic cardiomyopathy (HCM) (PMID: 25524337, 27532257). This variant has been reported in another individual affected with HCM, who also carried a pathogenic truncation variant in the same gene (PMID: 30896616). Additionally, this variant has been reported in three related individuals from an Italian family affected with HCM, who also carried a variant of uncertain significance in the MYH7 gene (Serio 2009). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). A different variant occurring at the same codon, p.Arg597Gln, is a well documented pathogenic mutation (Clinvar variation ID: 164098), indicating that arginine at this position is important for MYBPC3 protein function. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:2
The p.R597W variant (also known as c.1789C>T), located in coding exon 18 of the MYBPC3 gene, results from a C to T substitution at nucleotide position 1789. The arginine at codon 597 is replaced by tryptophan, an amino acid with dissimilar properties. This variant was reported in a compound heterozygous individual with hypertrophic cardiomyopathy (HCM), who had an MYBPC3 frameshift variant in trans, and was also reported in two unaffected relatives, who were heterozygous for R597W only (Chen X et al. Medicine (Baltimore), 2019 Mar;98:e14676). In addition, this alteration has been reported in HCM cohorts; however, limited clinical information was provided (Coppini R et al. J. Am. Coll. Cardiol., 2014 Dec;64:2589-2600; Walsh R et al. Genet. Med., 2017 Feb;19:192-203). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
PM2, PS4_supp, PP3 -
Cardiomyopathy Uncertain:1
This missense variant replaces arginine with tryptophan at codon 597 of the MYBPC3 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant.This variant has been reported in two unrelated individuals affected with hypertrophic cardiomyopathy (HCM) (PMID: 25524337, 27532257). This variant has been reported in another individual affected with HCM, who also carried a pathogenic truncation variant in the same gene (PMID: 30896616). Additionally, this variant has been reported in three related individuals from an Italian family affected with HCM, who also carried a variant of uncertain significance in the MYH7 gene (Serio 2009). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). A different variant occurring at the same codon, p.Arg597Gln, is a well documented pathogenic mutation (Clinvar variation ID: 164098), indicating that arginine at this position is important for MYBPC3 protein function. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at